In vitro study reveals rosmarinic acid mitigates doxorubicin-induced cardiotoxicity in H9c2 cells, suggesting a novel intervention.
Doxorubicin (DOX) is a potent chemotherapeutic agent widely used to treat various cancers, but its application is restricted by dose-limiting cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Al‐Hunaiti et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: